225 related articles for article (PubMed ID: 12942141)
1. In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3.
Gould TD; Chen G; Manji HK
Neuropsychopharmacology; 2004 Jan; 29(1):32-8. PubMed ID: 12942141
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of protein L-isoaspartyl methyltransferase expression by lithium is mediated by glycogen synthase kinase-3 inactivation and beta-catenin stabilization.
Lamarre M; Desrosiers RR
Neuropharmacology; 2008 Oct; 55(5):669-76. PubMed ID: 18582478
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum.
Alimohamad H; Rajakumar N; Seah YH; Rushlow W
Biol Psychiatry; 2005 Mar; 57(5):533-42. PubMed ID: 15737669
[TBL] [Abstract][Full Text] [Related]
4. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons.
Takahashi M; Yasutake K; Tomizawa K
J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium.
O'Brien WT; Harper AD; Jové F; Woodgett JR; Maretto S; Piccolo S; Klein PS
J Neurosci; 2004 Jul; 24(30):6791-8. PubMed ID: 15282284
[TBL] [Abstract][Full Text] [Related]
6. Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus.
Kaidanovich-Beilin O; Milman A; Weizman A; Pick CG; Eldar-Finkelman H
Biol Psychiatry; 2004 Apr; 55(8):781-4. PubMed ID: 15050857
[TBL] [Abstract][Full Text] [Related]
7. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
Lenox RH; McNamara RK; Watterson JM; Watson DG
J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
[TBL] [Abstract][Full Text] [Related]
8. The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells.
Laeng P; Pitts RL; Lemire AL; Drabik CE; Weiner A; Tang H; Thyagarajan R; Mallon BS; Altar CA
J Neurochem; 2004 Oct; 91(1):238-51. PubMed ID: 15379904
[TBL] [Abstract][Full Text] [Related]
9. The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats.
Alimohamad H; Sutton L; Mouyal J; Rajakumar N; Rushlow WJ
J Neurochem; 2005 Oct; 95(2):513-25. PubMed ID: 16144542
[TBL] [Abstract][Full Text] [Related]
10. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3.
Chen G; Huang LD; Jiang YM; Manji HK
J Neurochem; 1999 Mar; 72(3):1327-30. PubMed ID: 10037507
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3beta, beta-catenin, and tau in postmortem bipolar brain.
Lesort M; Greendorfer A; Stockmeier C; Johnson GV; Jope RS
J Neural Transm (Vienna); 1999; 106(11-12):1217-22. PubMed ID: 10651115
[TBL] [Abstract][Full Text] [Related]
12. Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death.
Jin N; Kovács AD; Sui Z; Dewhurst S; Maggirwar SB
Neuropharmacology; 2005 Mar; 48(4):576-83. PubMed ID: 15755485
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glycogen synthase kinase 3beta suppresses coxsackievirus-induced cytopathic effect and apoptosis via stabilization of beta-catenin.
Yuan J; Zhang J; Wong BW; Si X; Wong J; Yang D; Luo H
Cell Death Differ; 2005 Aug; 12(8):1097-106. PubMed ID: 15905881
[TBL] [Abstract][Full Text] [Related]
14. Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors.
Gould TD; Einat H; O'Donnell KC; Picchini AM; Schloesser RJ; Manji HK
Neuropsychopharmacology; 2007 Oct; 32(10):2173-83. PubMed ID: 17299510
[TBL] [Abstract][Full Text] [Related]
15. Effect of inhibition of glycogen synthase kinase-3 on cardiac hypertrophy during acute pressure overload.
Tateishi A; Matsushita M; Asai T; Masuda Z; Kuriyama M; Kanki K; Ishino K; Kawada M; Sano S; Matsui H
Gen Thorac Cardiovasc Surg; 2010 Jun; 58(6):265-70. PubMed ID: 20549454
[TBL] [Abstract][Full Text] [Related]
16. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium.
De Sarno P; Li X; Jope RS
Neuropharmacology; 2002 Dec; 43(7):1158-64. PubMed ID: 12504922
[TBL] [Abstract][Full Text] [Related]
18. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.
Leng Y; Liang MH; Ren M; Marinova Z; Leeds P; Chuang DM
J Neurosci; 2008 Mar; 28(10):2576-88. PubMed ID: 18322101
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glycogen synthase kinase-3β prevents sympathetic hyperinnervation in infarcted rats.
Lee TM; Lin SZ; Chang NC
Exp Biol Med (Maywood); 2015 Jul; 240(7):979-92. PubMed ID: 25576342
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent signaling pathway.
Debiais F; Lefèvre G; Lemonnier J; Le Mée S; Lasmoles F; Mascarelli F; Marie PJ
Exp Cell Res; 2004 Jul; 297(1):235-46. PubMed ID: 15194439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
